We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£76.93
This is the most expensive it has ever been. Walk away.
£77 today · previous high £77 · all-time low £77
Springer mTOR Inhibition for Cancer Therapy: Past, Present and Future
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 69 days · 69 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 69 days • 1 price levels
Price Analysis
Most common price: £77 (69 days, 100.0%)
Price range: £77 - £77
Price levels: 1 different prices over 69 days
Description
Product Specifications
- Brand
- Springer
- Format
- hardcover
- ASIN
- 2817804910
- Domain
- Amazon UK
- Publication Date
- 01 December 2015
- Listed Since
- 13 June 2013
Barcode
No barcode data available
Similar Products You Might Like
mTOR Pathway and mTOR Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)
Humana
Molecular Therapies of Cancer
Springer
Receptor Tyrosine Kinases in Cancer (Cancer Drug Discovery and Development)
Springer
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
Springer
Cancer Drug Discovery: Science and History
Springer
Molecularly Targeted Therapy for Childhood Cancer
Springer
Molecular Targeted Therapy of Lung Cancer
Springer
Molecular Oncology: Underlying Mechanisms and Translational Advancements
Springer
Nutraceuticals and Cancer
Springer
Cell Signaling & Molecular Targets in Cancer
Springer
Resistance to Proteasome Inhibitors in Cancer: Molecular Mechanisms and Strategies to Overcome Resistance (Resistance to Targeted Anti-Cancer Therapeutics)
Springer
Cancer II: 28 (Topics in Medicinal Chemistry, 28)
Springer
New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)
Springer
Targeting the Wnt Pathway in Cancer
Springer
Bioactive Natural Products for the Management of Cancer: from Bench to Bedside
Springer
Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology
Springer
The Rho GTPases in Cancer
Springer
Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
Springer
Targeted Interference with Signal Transduction Events: 172 (Recent Results in Cancer Research, 172)
Springer
Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)
Elsevier
Matrix Metalloproteinase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)
Springer
Cancer Immunotherapy: Immune Suppression and Tumor Growth
Academic Press
Targeting Autophagy in Cancer Therapy (Current Cancer Research)
Springer
Current Cancer Therapeutics
Springer